AYTU
Price
$2.25
Change
-$0.01 (-0.44%)
Updated
Sep 5 closing price
Capitalization
20.2M
ETON
Price
$17.67
Change
-$0.20 (-1.12%)
Updated
Sep 5 closing price
Capitalization
473.87M
66 days until earnings call
Interact to see
Advertisement

AYTU vs ETON

Header iconAYTU vs ETON Comparison
Open Charts AYTU vs ETONBanner chart's image
Aytu BioPharma
Price$2.25
Change-$0.01 (-0.44%)
Volume$50.5K
Capitalization20.2M
Eton Pharmaceuticals
Price$17.67
Change-$0.20 (-1.12%)
Volume$286.78K
Capitalization473.87M
AYTU vs ETON Comparison Chart in %
Loading...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYTU vs. ETON commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Buy and ETON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AYTU: $2.25 vs. ETON: $17.67)
Brand notoriety: AYTU and ETON are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 42% vs. ETON: 78%
Market capitalization -- AYTU: $20.2M vs. ETON: $473.87M
AYTU [@Pharmaceuticals: Generic] is valued at $20.2M. ETON’s [@Pharmaceuticals: Generic] market capitalization is $473.87M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whileETON’s FA Score has 1 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • ETON’s FA Score: 1 green, 4 red.
According to our system of comparison, ETON is a better buy in the long-term than AYTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 5 TA indicator(s) are bullish while ETON’s TA Score has 6 bullish TA indicator(s).

  • AYTU’s TA Score: 5 bullish, 4 bearish.
  • ETON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ETON is a better buy in the short-term than AYTU.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -4.26% price change this week, while ETON (@Pharmaceuticals: Generic) price change was +2.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

ETON is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETON($474M) has a higher market cap than AYTU($20.2M). ETON (32.658) and AYTU (32.353) have similar YTD gains . AYTU has higher annual earnings (EBITDA): 10.6M vs. ETON (1.84M). ETON has more cash in the bank: 25.4M vs. AYTU (18.2M). AYTU has less debt than ETON: AYTU (21.4M) vs ETON (30.7M). AYTU has higher revenues than ETON: AYTU (81.7M) vs ETON (58.2M).
AYTUETONAYTU / ETON
Capitalization20.2M474M4%
EBITDA10.6M1.84M575%
Gain YTD32.35332.65899%
P/E RatioN/A124.00-
Revenue81.7M58.2M140%
Total Cash18.2M25.4M72%
Total Debt21.4M30.7M70%
FUNDAMENTALS RATINGS
AYTU vs ETON: Fundamental Ratings
AYTU
ETON
OUTLOOK RATING
1..100
821
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
8696
PRICE GROWTH RATING
1..100
4637
P/E GROWTH RATING
1..100
666
SEASONALITY SCORE
1..100
756

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (42) in the Other Consumer Services industry is somewhat better than the same rating for ETON (86) in the Pharmaceuticals Major industry. This means that AYTU’s stock grew somewhat faster than ETON’s over the last 12 months.

ETON's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for AYTU (100) in the Other Consumer Services industry. This means that ETON’s stock grew significantly faster than AYTU’s over the last 12 months.

AYTU's SMR Rating (86) in the Other Consumer Services industry is in the same range as ETON (96) in the Pharmaceuticals Major industry. This means that AYTU’s stock grew similarly to ETON’s over the last 12 months.

ETON's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as AYTU (46) in the Other Consumer Services industry. This means that ETON’s stock grew similarly to AYTU’s over the last 12 months.

ETON's P/E Growth Rating (6) in the Pharmaceuticals Major industry is somewhat better than the same rating for AYTU (66) in the Other Consumer Services industry. This means that ETON’s stock grew somewhat faster than AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUETON
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 20 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QISGX31.580.24
+0.77%
Federated Hermes MDT Small Cap Growth IS
MOGLX10.190.04
+0.39%
Gabelli Media Mogul
PHSTX57.420.20
+0.35%
Putnam Global Health Care A
PWJZX35.04N/A
N/A
PGIM Jennison International Opps Z
SACEX9.06-0.10
-1.09%
Spirit of America Energy C

AYTU and

Correlation & Price change

A.I.dvisor indicates that over the last year, AYTU has been loosely correlated with IXHL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AYTU jumps, then IXHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-0.44%
IXHL - AYTU
41%
Loosely correlated
-9.48%
SBFM - AYTU
22%
Poorly correlated
-5.24%
PBH - AYTU
21%
Poorly correlated
-2.55%
CPHI - AYTU
21%
Poorly correlated
+16.32%
ETON - AYTU
20%
Poorly correlated
-1.12%
More

ETON and

Correlation & Price change

A.I.dvisor tells us that ETON and PCRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ETON and PCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-1.12%
PCRX - ETON
28%
Poorly correlated
-1.05%
ELAN - ETON
28%
Poorly correlated
+5.50%
TKNO - ETON
28%
Poorly correlated
+2.83%
HROW - ETON
28%
Poorly correlated
+2.18%
AQST - ETON
27%
Poorly correlated
+7.11%
More